Zanubrutinib: Revision history

From IDWiki

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

24 July 2025

  • curprev 13:5513:55, 24 July 2025 Aidan talk contribs 642 bytes +642 Created page with "* Bruton's tyrosine kinase inhibitor, inhibiting proliferation of malignant B cells * Half-life 2 to 4 hours * Adverse effects ** Atrial fibrillation, hypertension ** Rash ** Constipation, diarrhea, nausea, vomiting ** Fatigue, dizziness, headache ** Hemorrhage ** Myelosuppression ** Infections, including severe infections *** Pneumonia most common *** Hepatitis B virus and VZV reactivation ** Tumour lysis syndrome (in CLL) ** MSK pain ** Secondary ma..." Tag: Visual edit